SynthesisFrontiers in immunology2023

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.

Shuai Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.